Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Acute lymphocytic leukemia: Biological markers of clinical response
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Acute lymphocytic leukemia: Biological markers of clinical response'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Biological Marker
100%
Acute Lymphoblastic Leukemia
100%
Diseases
75%
High Risk Population
50%
Malignant Neoplasm
25%
Cell Population
25%
Tumor Cell
25%
Drug Resistance
25%
Cell Growth
25%
Karyotype
25%
Growth Regulation
25%
Treatment Outcome
25%
Immunology and Microbiology
High Risk Population
100%
Cell Population
50%
Tumor Cell
50%
Cell Growth
50%
Leukocyte Count
50%
Drug Resistance
50%
Growth Regulation
50%
Laboratory Technique
50%
Karyotype
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Acute Lymphoblastic Leukemia
100%
Diseases
75%
Malignant Neoplasm
25%
Drug Resistance
25%
Tumor Model
25%
Veterinary Science and Veterinary Medicine
Acute Lymphocytic Leukemia
100%
Diseases
75%
Leukocyte Count
25%
Neoplasm
25%
Cancer
25%
Keyphrases
Minimal Risk
25%